癌症中的免疫代谢生态系统
Glenn R Bantug1, Christoph Hess2,3
1Department of Biomedicine, Immunobiology, University of Basel and University Hospital of Basel, Basel, Switzerland. glenn.bantug@unibas.ch.
Nature immunology
|November 27, 2023
概括
准癌症代谢是有希望的,但具有挑战性. 抑制癌细胞代谢可以意外地促进瘤生长和抑制免疫反应,需要更广泛的治疗方法.
科学领域:
- 在瘤学瘤学.
- 癌症新陈代谢 癌症新陈代谢
- 瘤微环境 瘤微环境
背景情况:
- 癌细胞利用独特的代谢途径生存和增殖.
- 将代谢洞察转化为有效的临床癌症疗法仍然是一个重大挑战.
- 瘤微环境,包括非恶性细胞,在癌症进展中起着至关重要的作用.
研究的目的:
- 审查癌细胞和非恶性瘤细胞之间的代谢相互作用.
- 检查向癌症代谢如何影响瘤生态系统.
- 强调在开发代谢向癌症疗法的过程中需要采用整体方法.
主要方法:
- 关于癌症代谢和瘤微环境的当前文献的综述.
- 恶性和非恶性细胞之间的代谢交叉的分析.
- 评估代谢抑制剂对瘤居民细胞和免疫功能的影响.
主要成果:
- 向癌细胞中的特定代谢酶可能会对非恶性细胞产生意想不到的后果.
- 抑制癌症代谢可能会促进瘤生长,并创造一种免疫抑制的微环境.
- 代谢干预可以损害瘤特异性T细胞的功能.
结论:
- 对瘤的代谢生态系统的全面了解对于有效的癌症治疗至关重要.
- 针对新陈代谢的抗癌策略必须考虑对所有瘤居民细胞的更广泛影响.
- 需要采用整体方法来提高针对癌症代谢的药物的疗效.
相关概念视频
The Tumor Microenvironment
6.6K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.6K
Tumor Immunotherapy
529
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
529
Metastasis
5.6K
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
5.6K
mTOR Signaling and Cancer Progression
3.8K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.8K
Psychoneuroimmunology: Diabetes and Cancer
29
Chronic stress has been linked to both the onset and progression of serious health conditions, including Type 2 diabetes and cancer. Type 2 diabetes, a widespread chronic illness, is closely associated with obesity and insulin resistance, both of which often worsen under stress. Studies indicate that men experiencing high levels of chronic stress face a 45% higher risk of developing diabetes compared to those with minimal stress. Stress triggers physiological responses that elevate blood...
29
Mitogens and the Cell Cycle
6.5K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.5K


